Position
Creative Planning in Rhythm Pharmaceuticals, Inc.
Back to the book · All holders of RYTM
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark −$423.2K$107.04 → $86.97
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 25.2K | $2.7M | — | — | — | 0.0% |
| Q1 2026 | 21.1K | $1.83M | $86.97 | −$423.2K | −$441.1K | 0.0% |